Author Question: A monopolistically competitive firm that is incurring a loss will ________ as long as its revenue ... (Read 92 times)

danielfitts88

  • Hero Member
  • *****
  • Posts: 535

Question 1

If ________, then a profit-maximizing, monopolistically competitive firm earns positive economic profits.


P > 
ATC
P < 
ATC
P = 
ATC
◦ All of these are possible.

Question 2

A monopolistically competitive firm that is incurring a loss will ________ as long as its revenue covers variable costs.


◦ produce in the long run
◦ shut down in the short run
◦ earn a profit in the long run
◦ produce in the short run


stano32

  • Sr. Member
  • ****
  • Posts: 339

Answer 1

P > 
ATC

Answer 2

produce in the short run



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library